SCHEMBL17345908

SCHEMBL17345908

CCC(C)N(CCN(CCCSc1ccccc1)Cc1ccccc1)CC1CCCC1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.38
GRIN2B Q13224 2/20 0.38
GRIN2A Q12879 1/20 0.38
OPRM1 P35372 7/20 0.36
OPRD1 P41143 7/20 0.36
OPRK1 P41145 6/20 0.36
ATM Q13315 1/20 0.34
SLC2A1 P11166 1/20 0.34
BCHE P06276 1/20 0.34
ACHE P22303 1/20 0.32
RORC P51449 1/20 0.32
SLC22A2 O15244 1/20 0.32
SLC22A1 O15245 1/20 0.32
SLC22A3 O75751 1/20 0.32
ESR1 P03372 1/20 0.32
CHRM2 P08172 1/20 0.32
HTR1A P08908 1/20 0.32
ADRA2A P08913 1/20 0.32
ADORA3 P0DMS8 1/20 0.32
CHRM1 P11229 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17345913 0.99 ALDH1A1 (0.37) ALDH1A1GRIN2BGRIN2AOPRM1OPRD1
SCHEMBL17345917 0.86 SIGMAR1 (0.43) ALDH1A1GRIN2BGRIN2AOPRM1OPRD1
SCHEMBL17345912 0.85 FDPS (0.41) ALDH1A1GRIN2BGRIN2AOPRM1OPRD1
SCHEMBL17345910 0.84 FDPS (0.40) ALDH1A1GRIN2BGRIN2AOPRM1OPRD1
SCHEMBL17346117 0.83 ALDH1A1 (0.42) ALDH1A1GRIN2BGRIN2AOPRM1OPRD1
SCHEMBL17345988 0.82 ALDH1A1 (0.41) ALDH1A1GRIN2BGRIN2AOPRM1OPRD1
SCHEMBL17346129 0.78 ALDH1A1 (0.41) ALDH1A1GRIN2BGRIN2ASLC2A1BCHE
SCHEMBL17345916 0.77 SLC2A1 (0.39) ALDH1A1GRIN2BGRIN2AOPRM1ATM
SCHEMBL17346193 0.77 ALDH1A1 (0.41) ALDH1A1GRIN2BGRIN2ASLC2A1BCHE
SCHEMBL17346006 0.75 BCHE (0.49) ALDH1A1SLC2A1BCHERORCHRH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10550139-B2 Polydentate ligands and their complexes for molecular catalysis TRIAD NATIONAL SECURITY, LLC (US) 2020-02-04 US disclosed
US-20170088571-A1 POLYDENTATE LIGANDS AND THEIR COMPLEXES FOR MOLECULAR CATALYSIS TRIAD NATIONAL SECURITY, LLC 2017-03-30 US disclosed
US-20170088571-A1 POLYDENTATE LIGANDS AND THEIR COMPLEXES FOR MOLECULAR CATALYSIS TRIAD NATIONAL SECURITY, LLC 2017-03-30 US disclosed
WO-2015191505-A1 POLYDENTATE LIGANDS AND THEIR COMPLEXES FOR MOLECULAR CATALYSIS LOS ALAMOS NATIONAL SECURITY, LLC (US) 2015-12-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170088571-A1 POLYDENTATE LIGANDS AND THEIR COMPLEXES FOR MOLECULAR CATALYSIS NANS, NCL, NCLN ALDH1A1 862/4885GRIN2B 2436/4885GRIN2A 2548/4885
US-10550139-B2 Polydentate ligands and their complexes for molecular catalysis NANS, NCL, NCLN ALDH1A1 862/4885GRIN2B 2436/4885GRIN2A 2548/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.